Insider Transactions in Q1 2022 at Axonics, Inc. (AXNX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2022
|
Jane E Kiernan |
SELL
Open market or private sale
|
Direct |
5,250
-22.99%
|
$315,000
$60.75 P/Share
|
|
Mar 29
2022
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-20.52%
|
$3,000,000
$60.0 P/Share
|
|
Mar 18
2022
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,531
-24.34%
|
$771,267
$57.23 P/Share
|
|
Mar 14
2022
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-3.63%
|
$2,600,000
$52.65 P/Share
|
|
Mar 01
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
19,910
-19.21%
|
$1,134,870
$57.28 P/Share
|
|
Mar 01
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,329
+23.31%
|
$308,225
$25.82 P/Share
|
|
Feb 25
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-26.15%
|
$570,000
$57.0 P/Share
|
|
Feb 25
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.1%
|
$200,000
$20.01 P/Share
|
|
Feb 03
2022
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,115
-4.71%
|
$1,685,520
$48.62 P/Share
|
|
Feb 03
2022
|
Raymond W Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
96,846
+20.54%
|
-
|
|
Feb 03
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
18,684
-20.52%
|
$896,832
$48.62 P/Share
|
|
Feb 03
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,919
+44.04%
|
-
|
|
Feb 03
2022
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
9,267
-10.18%
|
$444,816
$48.62 P/Share
|
|
Feb 03
2022
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,130
+34.39%
|
-
|
|
Feb 03
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
6,251
-4.67%
|
$300,048
$48.62 P/Share
|
|
Feb 03
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,870
+23.69%
|
-
|
|
Feb 03
2022
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,882
-7.52%
|
$570,336
$48.62 P/Share
|
|
Feb 03
2022
|
Rinda Sama Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,311
+26.9%
|
-
|
|
Feb 03
2022
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,682
-5.4%
|
$320,736
$48.62 P/Share
|
|
Feb 03
2022
|
Karen Noblett Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,463
+23.81%
|
-
|
|
Feb 01
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
20,000
-20.25%
|
$960,000
$48.47 P/Share
|
|
Feb 01
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+40.0%
|
$280,000
$14.19 P/Share
|
|
Jan 31
2022
|
Raymond W Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,297
+13.48%
|
-
|
|
Jan 31
2022
|
Danny L. Dearen President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+34.38%
|
-
|
|
Jan 31
2022
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,285
+42.64%
|
-
|
|
Jan 31
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,425
+31.61%
|
-
|
|
Jan 31
2022
|
Rinda Sama Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,425
+29.86%
|
-
|
|
Jan 31
2022
|
Karen Noblett Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,350
+11.11%
|
-
|
|
Jan 18
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
20,000
-23.43%
|
$1,020,000
$51.21 P/Share
|
|
Jan 18
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+20.82%
|
$100,000
$5.75 P/Share
|